MediWound Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on December 16, 2024, by MediWound Ltd., a foreign private issuer based in Yavne, Israel, reports on insider share purchases. The filing covers transactions that occurred between December 9 and December 13, 2024.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on equity transactions by company insiders.
Material Changes
There are no material changes to the company's financial condition or operations reported in this filing. The only reported activity is the acquisition of 18,462 ordinary shares by the Chairman, CEO, and other Board members.
Management Commentary and Risks
Management confirms that the share purchases were conducted in open market transactions at an average price of $17.13 per share. The transactions adhered to the Company's insider trading policy. No new risks, contingencies, or unusual items are disclosed in this report.
Investor Verification Points
- Verify the aggregate purchase of 18,462 shares by insiders (Chairman Nachum Shamir, CEO Ofer Gonen, and other Board members).
- Confirm the average purchase price of $17.13 per share during the December 9–13, 2024 window.
- Note that this filing does not contain updated financial statements or operational results.